Association Between Antiangiogenic Drugs Used for Cancer Treatment and Artery Dissections or Aneurysms
Joris Guyon, Amandine Gouverneur, Sandy Maumus‐Robert, Xavier Bérard, Alexandre Pariente, Andréas Bikfalvi, Pernelle Noïze
Abstract
This pharmacovigilance study uses data from the World Health Organization database of adverse drug reactions to examine the association of antiangiogenic drugs with artery dissections or aneurysms among patients receiving antiangiogenic drugs for the treatment of cancer.
Topics & Concepts
MedicinePharmacovigilanceCancerAdverse effectDrugMEDLINEDrug reactionInternal medicineOncologySurgeryPharmacologyLawPolitical scienceRenal and Vascular PathologiesRenal cell carcinoma treatmentNeurological Complications and Syndromes